Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000s

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Albrecht, Katinka ^a   Huscher, Dörte ^a,b   Richter, Jutta ^c   Backhaus, Marina ^b   Bischoff, Sascha ^a   Kötter, Ina ^d   Thiele, Katja ^a   Zink, Angela ^a,b  

^a A Leibniz Institute   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; GLUCOCORTICOID; MYCOPHENOLATE MOFETIL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; GERMANY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84939545269     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000059     Document Type: Article

References (25)

1. Ruiz E, Ramalle-Gomara E, Elena A, et al. Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010. Lupus 2014;23:431-5.
2. Shen HN, Yang HH, Lu CL. Temporal trends in characteristics and outcome of intensive care unit patients with systemic lupus erythematosus in Taiwan: A national population-based study. Lupus 2013;22:644-52.
3. Cervera R, Khamashta MA, Hughes GR. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009;18:869-74.
4. Urowitz MB, Gladman DD, Ibanez D, et al. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) 2012;64:132-7.
5. Nossent J, Kiss E, Rozman B, et al. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus. Lupus 2010;19:949-56.
6. Zen M, Bassi N, Nalotto L, et al. Disease activity patterns in a monocentric cohort of SLE patients: A seven-year follow-up study. Clin Exp Rheumatol 2012;30:856-63.
7. Urowitz MB, Gladman DD, Tom BD, et al. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008;35:2152-8.
8. Neville C, Clarke AE, Joseph L, et al. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 2000;27:675-9.
9. Yen JC, Abrahamowicz M, Dobkin PL, et al. Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol 2003;30:1967-76.
10. Leong KP, Chong EY, Kong KO, et al. Discordant assessment of lupus activity between patients and their physicians: The Singapore experience. Lupus 2010;19:100-6.
11. Tamayo T, Fischer-Betz R, Beer S, et al. Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001-2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study). Lupus 2010;19:1606-13.
12. Baker K, Pope J, Fortin P, et al. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009;18:1281-8.
13. Yelin E, Tonner C, Trupin L, et al. Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012;64:169-75.
14. Zink A, Listing J, Klindworth C, et al. The National Database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Ann Rheum Dis 2001;60:199-206.
15. Lautenschlaeger J, Mau W, Kohlmann T, et al. [Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire] German. Z Rheumatol 1997;56:144-55.
16. Hart BI. Significance levels for the ratio of the mean square successive difference to the variance. Ann Math Statist 1942;13:445-7.
17. Belmont HM. Treatment of systemic lupus erythematosus-2013 update. Bull Hosp Jt Dis 2013;71:208-13.
18. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73:958-67.
19. Drenkard C, Bao G, Dennis G, et al. Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States. Arthritis Care Res (Hoboken) 2014;66:878-87.
20. Mau W, Thiele K, Lamprecht J. [Trends of work force participation of patients with rheumatic diseases : results from German social insurance data and the national database of the German collaborative arthritis centers]. Z Rheumatol 2014;73:11-19.
21. The information system of the Federal Health Monitoring. http://www. gbe-bund.de Diagnostic data of the hospitals. Average length of stay. Classification: years, age, sex, specialist department. 2014.
22. Huscher D, Mittendorf T, von HU, et al. Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis Published Online First: 9 Jan 2014. doi:10.1136/annrheumdis-2013-204311
23. Zink A, Fischer-Betz R, Thiele K, et al. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. Lupus 2004;13:529-36.
24. Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol 2006;24(6 Suppl 43): S-99-104.
25. Huscher D, Albrecht K, Bischoff S, et al. Increasing disparities between physician assessment of disease acitivity and patient global health in Germany between 2000 and 2012. EULAR, Paris, 2014. Ann Rheum Dis 2014;73(supp 2):336 [abstract].